期刊文献+

槐定碱结构改造及其抗肿瘤活性 被引量:2

Structural modification of sophoridine and their antimumor activity
暂未订购
导出
摘要 目的:对槐定碱进行结构改造,合成新型槐定碱衍生物,研究其抗肿瘤活性。方法:以槐定碱为原料,合成了8个14位取代槐定碱衍生物,其结构经1H-NMR,MS证实。经MTT法筛选了衍生物对肝癌、肺癌、结肠癌、胃癌、神经胶质瘤、脑胶质瘤、宫颈癌以及黑色素瘤的抗癌活性。结果:合成的8个槐定碱衍生物中有6个是14位不同构型的槐定碱衍生物。实验显示14位为氯取代的化合物①、②、③和⑧对大部分肿瘤细胞的抑制活性均明显高于槐定碱。结论:在槐定碱14位引入氯原子取代可提高槐定碱的抗肿瘤活性。 Objective :To study the relationship between the novel sophoridine derivatives which synthesized by structural modification and its antitumor activity. Method :8 sophoridine derivatives which substituted at 14 position have been synthesized and their structures were conformed by 1 H - NMR and MS. The antitumor activities against such as live cancer, lung cancer, colon cancer, gastric cancer, glioblastomas, cervical cancer, melanoma were determined by MTT methods. Results:6 out of total 8 compounds were sophoridine derivatives with different configuration at 14 position. Results showed the antitumor activites of 14 - chloro substitued compounds 1,2, 3, 8 are better than sophoridine in most tumor cells. Conclusion:Substitution by chlorine at 14 position of sophoridine can enhance the antitumor activity of sophoridine.
出处 《天津药学》 2013年第4期1-5,共5页 Tianjin Pharmacy
关键词 槐定碱 抗肿瘤 结构改造 合成 sophoridine antitumor structural modification synthesis
  • 相关文献

参考文献5

二级参考文献79

共引文献96

同被引文献18

  • 1吴清,任天池,张玲,石红欣,张永强.槐定碱白蛋白微球制备工艺研究[J].北京中医药大学学报,2006,29(8):551-554. 被引量:7
  • 2黄圣凯,陈静芬,谢永新,等.槐定碱的气相色谱测定法及其在兔体内的药代动力学[J].药学学报,1988,23(8):561-565.
  • 3葛蔓,全东琴.高靶向载体给药系统的分类及其设计原理[C]//2008年中国药学会学术年会暨第八届中国药师周论文集.北京:中国药学会,2008:2203-2210.
  • 4Choi H S,Seo S A,Khang G,et al.Preparation and characterization of fentanyl-loaded PLGA microspheres:in vitro release profiles[J].Int J Pharm,2002,234(3):195-203.
  • 5Hongkee S.Microencapsulation techniques using ethyl acetate as a dispersed solvent:effects of its extraction rate on the characteristics of PLGA microspheres[J].J Controlled Release,1997,47(3):233-245.
  • 6Li W I,Anderson K W,Deluca P P.Kinetic and thermodynamic modeling of the formation of polymeric microspheres using solvent extraction/evaporation method[J].J Controlled Release,1995,37(3):187-198.
  • 7Chung T W,Huang Y Y,Liu Y Z.Effects of the rate of solvent evaporation on the characteristics of drug loaded PLLA and PLLA microspheres[J].Int J Pharm,2001,212(3):161-169.
  • 8Gupte A,Ciftci K.Formulation and characterization of Paclitaxel,5-FU and Paclitaxel+5-FU microspheres[J].Int J Pharm,2004,276(1-2):93-106.
  • 9Maurya S D,Dhakar R C,Aggarawal S,et al.Design and evaluation of SRM microsphere of metformin hydrochloride[J].IJCP,2010,1(7):1-5.
  • 10Sirsi S R,Schray R C,Wheatley M A,et al.Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)poly(ethylene glycol)copolymers complexed to oligonucleotides[J].J Nanobiotechnol,2009,7:1-12.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部